BACKGROUND: The role of myeloid-derived suppressor cells (MDSCs) in patients with severe tuberculosis who suffer from uncontrolled pulmonary inflammation caused by hypervirulent mycobacterial infection remains unclear. METHODS: This issue was addressed using C57BL/6 mice infected with highly virulent Mycobacterium bovis strain MP287/03. RESULTS: CD11b+GR1int population increased in the bone marrow, blood and lungs during advanced disease. Pulmonary CD11b+GR1int (Ly6GintLy6Cint) cells showed granularity similar to neutrophils and expressed immature myeloid cell markers. These immature neutrophils harbored intracellular bacilli and were preferentially located in the alveoli. T-cell suppression occurred concomitantly with CD11b+GR1int cell accumulation in the lungs. Furthermore, lung and bone marrow GR1+ cells suppressed both T-cell proliferation and interferon γ production in vitro. Anti-GR1 therapy given when MDSCs infiltrated the lungs prevented expansion and fusion of primary pulmonary lesions and the development of intragranulomatous caseous necrosis, along with increased mouse survival and partial recovery of T-cell function. Lung bacterial load was reduced by anti-GR1 treatment, but mycobacteria released from the depleted cells proliferated extracellularly in the alveoli, forming cords and clumps. CONCLUSIONS: Granulocytic MDSCs massively infiltrate the lungs during infection with hypervirulent mycobacteria, promoting bacterial growth and the development of inflammatory and necrotic lesions, and are promising targets for host-directed therapies.
BACKGROUND: The role of myeloid-derived suppressor cells (MDSCs) in patients with severe tuberculosis who suffer from uncontrolled pulmonary inflammation caused by hypervirulent mycobacterial infection remains unclear. METHODS: This issue was addressed using C57BL/6 miceinfected with highly virulent Mycobacterium bovis strain MP287/03. RESULTS:CD11b+GR1int population increased in the bone marrow, blood and lungs during advanced disease. Pulmonary CD11b+GR1int (Ly6GintLy6Cint) cells showed granularity similar to neutrophils and expressed immature myeloid cell markers. These immature neutrophils harbored intracellular bacilli and were preferentially located in the alveoli. T-cell suppression occurred concomitantly with CD11b+GR1int cell accumulation in the lungs. Furthermore, lung and bone marrow GR1+ cells suppressed both T-cell proliferation and interferon γ production in vitro. Anti-GR1 therapy given when MDSCs infiltrated the lungs prevented expansion and fusion of primary pulmonary lesions and the development of intragranulomatous caseous necrosis, along with increased mouse survival and partial recovery of T-cell function. Lung bacterial load was reduced by anti-GR1 treatment, but mycobacteria released from the depleted cells proliferated extracellularly in the alveoli, forming cords and clumps. CONCLUSIONS: Granulocytic MDSCs massively infiltrate the lungs during infection with hypervirulent mycobacteria, promoting bacterial growth and the development of inflammatory and necrotic lesions, and are promising targets for host-directed therapies.
Authors: Felix Roth; Adriana C De La Fuente; Jennifer L Vella; Alessia Zoso; Luca Inverardi; Paolo Serafini Journal: Cancer Res Date: 2012-01-26 Impact factor: 12.701
Authors: José Medina-Echeverz; Lydia A Haile; Fei Zhao; Jaba Gamrekelashvili; Chi Ma; Jean-Yves Métais; Cynthia E Dunbar; Veena Kapoor; Michael P Manns; Firouzeh Korangy; Tim F Greten Journal: Eur J Immunol Date: 2014-06-16 Impact factor: 5.532
Authors: J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun Journal: N Engl J Med Date: 2001-10-11 Impact factor: 91.245
Authors: Eduardo P Amaral; Érika Machado de Salles; Caio Cesar Barbosa Bomfim; Rafael Moysés Salgado; Fabrício M Almeida; Paula Carolina de Souza; José Maria Alvarez; Mario H Hirata; Elena B Lasunskaia; Maria Regina D'Império-Lima Journal: J Infect Dis Date: 2019-02-23 Impact factor: 5.226
Authors: Thomas J Scriba; Adam Penn-Nicholson; Smitha Shankar; Tom Hraha; Ethan G Thompson; David Sterling; Elisa Nemes; Fatoumatta Darboe; Sara Suliman; Lynn M Amon; Hassan Mahomed; Mzwandile Erasmus; Wendy Whatney; John L Johnson; W Henry Boom; Mark Hatherill; Joe Valvo; Mary Ann De Groote; Urs A Ochsner; Alan Aderem; Willem A Hanekom; Daniel E Zak Journal: PLoS Pathog Date: 2017-11-16 Impact factor: 6.823
Authors: Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima Journal: PLoS Pathog Date: 2014-07-03 Impact factor: 6.823